REGINA TOLSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner EAST BERNSTADT, KY NPI 1740943265

General Payments — all program years on this page

$1,108.28

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 48
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $355.89 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $355.8922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $168.347
2023 $584.0519
2024 $355.8922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100244121 Novo Nordisk Inc $15.23 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100264498 Novo Nordisk Inc $16.57 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100306179 Novo Nordisk Inc $18.93 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100309271 Novo Nordisk Inc $15.20 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100340558 Novo Nordisk Inc $17.66 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100447045 Novo Nordisk Inc $18.93 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100448485 Novo Nordisk Inc $12.13 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100483153 Novo Nordisk Inc $18.57 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100493329 Novo Nordisk Inc $16.61 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100494835 Novo Nordisk Inc $13.23 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100502063 Novo Nordisk Inc $14.52 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100573508 Novo Nordisk Inc $6.33 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100599113 Novo Nordisk Inc $19.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100602938 Novo Nordisk Inc $17.48 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100609738 Novo Nordisk Inc $1.79 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100619908 Novo Nordisk Inc $15.91 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118843885 Otsuka Pharmaceutical Development & Commercialization, Inc. $34.83 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135900540 Lilly USA, LLC $15.23 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135919772 Lilly USA, LLC $15.88 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135928334 Lilly USA, LLC $15.00 07/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135950822 Lilly USA, LLC $17.05 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144637226 Xeris Pharmaceuticals, Inc. $19.81 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.